Resources
The latest in drug discovery, from novel targets and screening tools through to automation and computational chemistry
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Target Based Discovery
Post-Event Proceedings – Discovery Europe 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Discovery Europe 2023.
Target Based Discovery
Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery
Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Target Based Discovery
Navigating DEL Screening from Hit to Lead
The panel at Drug Discovery US discussed hit finding technologies, protein availability for screening, and hit-to-lead transition.
Target Based Discovery
Tailor-made ADME-Tox
Admescope is a contract research organisation (CRO) providing the pharmaceutical industry with tailor-made ADME-Tox services to support the discovery and development of small molecules and biologics.
Target Based Discovery
Biotechne: Your Complete Protein Analysis Solution
Protein analysis comes with many challenges—labor-intensive protocols increase time to result and multiple hands-on steps increase user error and data variability
Target Based Discovery
Biotechne: Service and Support Plans
Proteinsimple, a bio-techne brand, is here to support your research at every step of the way.
Target Based Discovery
Potential Antidote Discovered for Centuries-Old Toxic Mushroom
Researchers have discovered a potential antidote, indocyanine green (ICG), for the highly toxic death cap mushroom, Amanita phalloides.
Target Based Discovery
How DEL Screening is Used in Living Cells
Living cells create a more relevant physiological environment for DEL screening, says Dr Iolanda Micco, Associate Director of Chemistry & Alliances at Vipergen
Target Based Discovery
First Paediatric Patients Enrolled in Phase III Clinical Trial for Rare Genetic Disease
A clinical trial for the drug leniolisib will go ahead in studying paediatric patients with the rare genetic disease ADPS.
Target Based Discovery
Addressing Specific Targets and Dealing with Target Engagement
The panel discussion from Discovery US 2022, investigates into new technologies for target engagement and expanding the chemical space.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery